Return On Equity of Alzamend Neuro, Inc. from 30 Apr 2022 to 30 Apr 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alzamend Neuro, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Apr 2022 to 30 Apr 2025.
  • Alzamend Neuro, Inc. Return On Equity for the quarter ending 30 Apr 2025 was -181%, a 144% decline year-over-year.
  • Alzamend Neuro, Inc. annual Return On Equity for 2024 was 187%.
  • Alzamend Neuro, Inc. annual Return On Equity for 2023 was -138%, a 24% decline from 2022.
  • Alzamend Neuro, Inc. annual Return On Equity for 2022 was -111%, a 100% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Alzamend Neuro, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -181% -594% -144% 01 Feb 2025 30 Apr 2025
Q4 2024 -498% -1734% -140% 01 Nov 2024 31 Jan 2025
Q3 2024 542% +1535% 01 Aug 2024 31 Oct 2024
Q2 2024 275% +625% 01 May 2024 31 Jul 2024
Q1 2024 412% 01 Feb 2024 30 Apr 2024
Q4 2023 1236% 01 Nov 2023 31 Jan 2024
Q3 2023 -993% 01 Aug 2023 31 Oct 2023
Q2 2023 -350% 01 May 2023 31 Jul 2023

Alzamend Neuro, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 187% 01 May 2024 30 Apr 2025
2023 -138% -27% -24% 01 May 2023 30 Apr 2024
2022 -111% +64867% +100% 01 May 2022 30 Apr 2023
2021 -64978% 01 May 2021 30 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.